Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 1Resectable Pancreatic Carcinoma 1Rectal Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Breast Neoplasms 1Adenocarcinoma of the Pancreas 1

Interventions

pembrolizumab 1paricalcitol 1Taxes 1Gemcitabine 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Resectable Pancreatic Carcinoma × paricalcitol × Clear all
NCT02930902 2023-02-09

Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery

M.D. Anderson Cancer Center

Phase 1 Completed
9 enrolled
Gastrointestinal

Resectable Pancreatic Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡